Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin follow-on therapy for prevention of recurrent Clostridioides difficile-associated diarrhoea
2012-003205-10Phase 4Terminated
- Sponsor
- University of Nottingham
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rifaximin in Clostridioides difficile colitis (CDI), sponsored by University of Nottingham. Started Aug 2012; status: terminated.
02
Drugs
rifaximin
03
Conditions
Clostridioides difficile colitis (CDI)
Beyond the preview
Go deeper on 2012-003205-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003205-10.